Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « FC03.fr.i » - entrée « Primates »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Primaire < Primates < Primidone  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000310 (2012) Susan H. Fox [Canada] ; Tom H. Johnston [Canada] ; QIN LI [République populaire de Chine] ; Jonathan Brotchie [Canada] ; Erwan Bezard [République populaire de Chine, France]A Critique of Available Scales and Presentation of the Non-Human Primate Dyskinesia Rating Scale
000383 (2011) Christopher Kobylecki [Royaume-Uni] ; Michael P. Hill [Canada] ; Alan R. Crossman [Royaume-Uni] ; Paula Ravenscroft [Royaume-Uni, Canada]Synergistic Antidyskinetic Effects of Topiramate and Amantadine in Animal Models of Parkinson's Disease
000558 (2011) Anne-Sophie Rolland [France] ; Carine Karachi [France] ; Marie-Paule Muriel [France] ; Etienne C. Hirsch [France] ; Chantal Francois [France]Internal Pallidum and Substantia Nigra Control Different Parts of the Mesopontine Reticular Formation in Primate
000694 (2011) Raymond T. Bartus [États-Unis] ; Christopher D. Herzog [États-Unis] ; YAPING CHU [États-Unis] ; Alistair Wilson [États-Unis] ; Lamar Brown [États-Unis] ; Joao Siffert [États-Unis] ; Eugene M. Jr Johnson [États-Unis] ; C. Warren Olanow [États-Unis] ; Elliott J. Mufson [États-Unis] ; Jeffrey H. Kordower [États-Unis]Bioactivity of AAV2-Neurturin Gene Therapy (CERE-120): Differences Between Parkinson's Disease and Nonhuman Primate Brains
000731 (2011) Erwan Bezard [France] ; Serge Przedborski [États-Unis]A Tale on Animal Models of Parkinson's Disease
000781 (2010) Tom H. Johnston [Canada] ; Susan H. Fox [Canada] ; Matthew J. Piggott [Australie] ; Juha-Matti Savola [Suisse] ; Jonathan M. Brotchie [Canada]The α2 Adrenergic Antagonist Fipamezole Improves Quality of Levodopa Action in Parkinsonian Primates
000898 (2010) Kayhan A. Tayarani-Binazir [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; C. Warren Olanow [États-Unis] ; Peter Jenner [Royaume-Uni]Pramipexole Combined with Levodopa Improves Motor Function but Reduces Dyskinesia in MPTP-Treated Common Marmosets
000A42 (2010) Tomas Bjorklund [Suède] ; Jeffrey H. Kordower [États-Unis]Gene Therapy for Parkinson's Disease
001054 (2008) Naomi P. Visanji [Canada] ; Rob M. A. De Bie [Canada] ; Tom H. Johnston [Canada] ; Andrew C. Mccreary [Pays-Bas] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]The Nociceptin/Orphanin FQ (NOP) Receptor Antagonist J-113397 Enhances the Effects of Levodopa in the MPTP-Lesioned Nonhuman Primate Model of Parkinson's Disease
001125 (2008) Peter Jenner [Royaume-Uni]Preventing and Controlling Dyskinesia in Parkinson's Disease : A View of Current Knowledge and Future Opportunities
001863 (2006) Susan H. Fox [Canada] ; Anthony E. Lang [Canada] ; Jonathan M. Brotchie [Canada]Translation of nondopaminergic treatments for levodopa-induced dyskinesia from MPTP-lesioned nonhuman primates to phase IIa clinical studies : Keys to success and roads to failure
001966 (2006) Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease
001A72 (2006) Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Naomi P. Visanji [Canada] ; Susan H. Fox [Canada] ; Jonathan M. Brotchie [Canada]Histamine H3 receptor agonists reduce L-dopa-induced chorea, but not dystonia, in the MPTP-lesioned nonhuman primate model of parkinson's disease
001C94 (2005) Carine Karachi [France] ; Jérome Yelnik [France] ; Dominique Tande [France] ; Léon Tremblay [France] ; Etienne C. Hirsch [France] ; Chantal Francois [France]The pallidosubthalamic projection : An anatomical substrate for nonmotor functions of the subthalamic nucleus in primates
001F79 (2004) Matthew J. Hansard [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Sharon C. Cheetham [Royaume-Uni] ; Peter Jenner [Royaume-Uni]The monoamine reuptake inhibitor BTS 74 398 fails to evoke established dyskinesia but does not synergise with levodopa in MPTP-treated primates
002091 (2004) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ghassan Al-Barghouthy [Royaume-Uni] ; Sarah Rose [Royaume-Uni] ; Mikko Kuoppamaki [Royaume-Uni, États-Unis] ; Warren Olanow [Finlande] ; Peter Jenner [Royaume-Uni]Multiple small doses of levodopa plus entacapone produce continuous dopaminergic stimulation and reduce dyskinesia induction in MPTP-treated drug-naïve primates
002472 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of Levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure
002685 (2002) Igor A. Ilinsky [États-Unis] ; Kristy Kultas-Ilinsky [États-Unis]Motor thalamic circuits in primates with emphasis on the area targeted in treatment of movement disorders
002916 (2001) G. M. Petzinger [États-Unis] ; M. Quik [États-Unis] ; E. Ivashina [États-Unis] ; M. W. Jakowec [États-Unis] ; M. Jakubiak [États-Unis] ; D. Di Monte [États-Unis] ; J. W. Langston [États-Unis]Reliability and validity of a new global dyskinesia rating scale in the MPTP-lesioned non-human primate
002A60 (2001) Eleni C. Maratos [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Ronald K. B. Pearce [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Antiparkinsonian activity and dyskinesia risk of ropinirole and L-DOPA combination therapy in drug naïve MPTP-lesioned common marmosets (Callithrix jacchus)
003095 (1998) P. A. Lapchak [États-Unis]A preclinical development strategy designed to optimize the use of glial cell line-derived neurotrophic factor in the treatment of Parkinson's disease

List of associated Author.i

Nombre de
documents
Descripteur
6Peter Jenner
6Susan H. Fox
5Jonathan M. Brotchie
5Michael J. Jackson
5Tom H. Johnston
3Lance A. Smith
3Naomi P. Visanji
2C. Warren Olanow
2Carine Karachi
2Chantal Francois
2Erwan Bezard
2Etienne C. Hirsch
2Jeffrey H. Kordower
2Jordi Gomez-Ramirez
2Matthew J. Hansard
2Sarah Rose
1A. Benazzouz
1Alan R. Crossman
1Alistair Wilson
1Andrew C. Mccreary
1Anne-Sophie Rolland
1Anthony E. Lang
1B. Bioulac
1C. Gross
1Christopher D. Herzog
1Christopher Kobylecki
1D. Di Monte
1Dominique Tande
1Donna Pires
1E. Ivashina
1Eleni C. Maratos
1Eleni Maratos
1Elliott J. Mufson
1Eugene M. Jr Johnson
1G. M. Petzinger
1Ghassan Al-Barghouthy
1Igor A. Ilinsky
1J. Feger
1J. W. Langston
1Joao Siffert
1Jonathan Brotchie
1Juha-Matti Savola
1Jérome Yelnik
1Kayhan A. Tayarani-Binazir
1Kristy Kultas-Ilinsky
1Lamar Brown
1Léon Tremblay
1M. Jakubiak
1M. Quik
1M. W. Jakowec
1Marie-Paule Muriel
1Matthew J. Piggott
1Michael P. Hill
1Mikko Kuoppamaki
1P. A. Lapchak
1P. Burbaud
1Paula Ravenscroft
1QIN LI
1Raymond T. Bartus
1Rob M. A. De Bie
1Ronald K. B. Pearce
1Serge Przedborski
1Sharon C. Cheetham
1T. Boraud
1Tomas Bjorklund
1Valerie Voon
1Warren Olanow
1YAPING CHU

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i -k "Primates" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/FC03.fr.i  \
                -Sk "Primates" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    FC03.fr.i
   |clé=    Primates
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024